Sartorius

Virocell Biologics is a contract development and manufacturing organization that specializes in the production of viral vectors and gene-modified cells. The company focuses on facilitating the development of novel cell and gene therapies, allowing these innovations to progress into clinical trials. Virocell Biologics offers a platform designed to ensure a rapid, safe, and reliable transition from laboratory research to clinical application, thereby reducing risks and enhancing the value of emerging therapies. Through its services, Virocell Biologics supports medical researchers by providing the necessary gene-modified cells for their clinical studies.

TheWell Bioscience is a biotechnology company that specializes in 3D cell culture technology aimed at enhancing life science research. The company has developed an innovative cell culture hydrogel system designed to facilitate drug screening, tissue engineering, and pre-clinical studies. By bridging the gap between traditional in vitro studies and in vivo models, TheWell Bioscience provides researchers with a robust platform for drug discovery and personalized medicine. This technology supports scientists in their efforts to conduct more accurate and relevant analyses, ultimately advancing the healthcare industry.

SPARTA Biodiscovery offers Facilitating nanoformulations for upcoming therapies.

Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.

Albumedix is a biotechnology company based in Nottingham, England, that specializes in developing albumin-based drug enhancement technologies to create superior biopharmaceuticals. With a focus on improving therapies for serious diseases, the company partners with pharmaceutical organizations to deliver advanced drug and vaccine formulations. Its product offerings include drug stabilization, cell therapy formulation, and drug conjugates, which help clients in formulating effective treatments. With a dedicated team of over 80 professionals, Albumedix is recognized as a leader in the industry, contributing to both clinical and marketed drugs while remaining committed to enhancing patient quality of life through innovative albumin-enabled therapies.

Novasep - Chromatography Equipment comprises resin-based batch and intensified chromatography systems, and focuses on low & high pressure for small and large molecules such as monoclonal antibodies, oligonucleotides, peptides and insulin.

ALS Automated Lab Solutions specializes in providing advanced laboratory services tailored for life science applications. Its flagship product, the ALS CellCelector, is an automated system designed for mammalian cell line generation. This innovative platform enables the scanning of cell culture plates to identify and select target cells or colonies with high precision. By integrating advanced robotic technology with sophisticated image processing software, the CellCelector offers exceptional image quality and real-time quality control during the picking process. The use of disposable tips eliminates the risk of cross-contamination, while the system's design ensures minimal maintenance requirements. Overall, ALS Automated Lab Solutions aims to enhance efficiency and accuracy in laboratory workflows, ultimately benefiting scientists in their research endeavors.

Xell is a partner for biotech and pharmaceutical companies, specializing in cell culture technology to enhance the production of biopharmaceuticals, diagnostic proteins, viral vectors, and vaccines. The company offers a diverse product portfolio that includes cell culture media, feeds, dietary supplements, and customized formulations tailored to meet the specific needs of its clients. With a team of experienced experts, Xell focuses on delivering efficient solutions for cell culture challenges, leveraging advanced analytical tools for the characterization of biological systems and pharmaceutical proteins. By collaborating closely with customers, Xell aims to optimize their bioprocesses and improve overall production capabilities in the healthcare sector.

They develop, manufacture and market human cytokines, growth factors, and other recombinant cell culture components in preclinical and GMP quality as well as proprietary serum-free media for further manufacturing of ATMPs. Their products are used by academia and industry partners in clinical trials and commercial manufacturing throughout the world. As an ATMP developer and manufacturer they gained in-depth cell culture knowledge and superior regulatory expertise. With this unique background they understand the high requirements their customers face during product development and the regulatory approval process.

Biological Industries is a manufacturer focused on developing life science research products, particularly in the areas of cell culture and molecular biology. The company specializes in creating cell culture media tailored for stem cell research and potential cell therapy applications. Its offerings include products for stem cell culture and differentiation, human cytogenetics, tissue culture, and custom cell media formulation. Additionally, Biological Industries provides services in contract manufacturing, mycoplasma detection and elimination, as well as cell proliferation and viability assessments. Furthermore, the company produces QF-PCR test kits, supporting academic institutions, biotechnology firms, and pharmaceutical companies with innovative solutions in the fields of cell therapy and molecular biology.

Danaher Life Sciences provide scientists with meaningful research tools and services to gain a better understanding of biological and chemical matters. The combined efforts of Beckman Coulter Life Sciences, SCIEX, Molecular Devices, Pall, and Leica Microsystems work synergistically to provide increasingly sophisticated technologies designed to integrate across systems faster and with more accurate data.

ForteBio is a venture-capital funded life science company developing analytical systems to provide rapid, real-time results for protein quantification or characterization of protein-protein interaction. These systems enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics, and concentration.

MKS Umetrics is a prominent provider of data analytics software focused on enhancing biopharmaceutical development and manufacturing processes. The company's software solutions include tools for predictive modeling, design of experiments (DOE), and multivariate data analysis (MVDA). These offerings enable clients to optimize their operations and improve decision-making by leveraging advanced analytical methodologies. Through its innovative software, MKS Umetrics aims to add significant value to businesses in the biopharmaceutical sector.

Essen BioScience is a world leader in the field of cell-based in vitro assays and instrumentation. Our inventions have spanned nearly twenty years, and are recognized as “first in class” in several technology areas including optical cell-based screening (FLIPR, 1994), high through electrophysiology (IonWorks, 2002) and kinetic imaging (IncuCyte, 2006; IncuCyte ZOOM, 2012). To date, our inventions have accounted for nearly 1 billion dollars in worldwide sales.

ViroCyt focuses on the commercialization of novel technologies that enable the rapid quantification of viruses. Our goal is to provide the tools that deliver meaningful improvements to mission-critical processes, such as vaccine manufacturing, protein expression, antiviral development, and other settings where viruses play a significant role. It was founded in 2012 and is based in Broomfield, Colorado.

kSep Systems, LLC specializes in automated single-use bioprocessing solutions tailored for the biopharmaceutical industry, particularly in recombinant therapeutics, cell therapy, and vaccine manufacturing. The company's flagship technology, kSep, enables efficient harvesting of cells as either a product or by-product during the manufacturing process. This innovative system retains particles, such as cells or microcarriers, in a concentrated fluidized bed while maintaining a continuous flow of media or buffer. kSep Systems addresses the limitations of traditional centrifugation methods by providing fully automated, gentle processing environments that enhance the concentration, washing, and separation of cells, thereby ensuring high recovery rates. Founded in 2011 and headquartered in Morrisville, North Carolina, kSep Systems operates as a subsidiary of Sartorius Stedim Biotech S.A., building on its legacy as a former subsidiary of KBI Biopharma Inc.

IntelliCyt Corporation specializes in the development of high-throughput cell- and bead-based screening solutions tailored for the life sciences sector, particularly in drug discovery, antibody development, and immunology. Founded in 2006 and based in Albuquerque, New Mexico, the company offers a comprehensive iQue Screener platform that integrates instrumentation, software, and reagents to facilitate high-content multiplex analysis of samples in liquid suspension. This platform is complemented by ForeCyt software for data visualization and analysis, as well as MultiCyt screening kits designed for use with iQue Screeners. IntelliCyt’s innovative technologies significantly enhance the efficiency and cost-effectiveness of detecting and measuring cells and beads, addressing critical needs in pharmaceutical and biotechnology laboratories globally. As a subsidiary of Sartorius AG, IntelliCyt continues to lead in providing solutions that meet the demands of modern life sciences research while ensuring rapid and relevant results in various applications, including phenotypic small molecule drug discovery and in vitro toxicology.

Cellca is a specialized technology and service provider that focuses on upstream technologies for mammalian protein manufacturing. The company develops cell lines and offers fermentation processes for biopharmaceutical products, emphasizing process development for large-scale production of biologics in mammalian cells. Cellca's proprietary technologies are designed to enhance the efficiency, robustness, and scalability of mammalian protein manufacturing, making it faster and more cost-effective.

TAP Biosystems specialise in the design and manufacture of automated cell culture and fermentation systems.